Literature DB >> 16905210

Cardiac and pulmonary complication probabilities for breast cancer patients after routine end-inspiration gated radiotherapy.

Stine S Korreman1, Anders N Pedersen, Mirjana Josipović, Lasse Rye Aarup, Trine Juhler-Nøttrup, Lena Specht, Håkan Nyström.   

Abstract

PURPOSE: Substantial reductions of radiation doses to heart and lung can be achieved using breathing adaptation of adjuvant radiotherapy following conservative surgery for breast cancer. The purpose of this study was to estimate the radiobiological implications after routine use of an end-inspiration gated treatment, and to compare the results with predictions based on pre-clinical CT-studies. PATIENTS AND METHODS: Nineteen consecutive patients with axillary lymph node-positive left-sided breast cancer were referred for adjuvant radiotherapy after breast conserving surgery. Treatment was performed with gating in the end-inspiration phase of audio-coached enhanced free breathing. The target intended to encompass the remaining breast, ipsilateral internal mammary and periclavicular nodes, and the prescription dose was 48Gy in 24 fractions. A three-field mono-isocentric conformal technique using deep tangentials and a supraclavicular field was employed. NTCPs were calculated using the relative seriality model for the heart, and the model proposed by Burman et al. for the lung. The observed values were compared to those predicted from two previous CT-studies for a deep inspiration breath-hold technique and an uncoached end-inspiration gating technique.
RESULTS: The ipsilateral lung V(50) (relative volume receiving more than 50% of the prescription dose) had a median value of 23.7% (range 10.8-35.1%) over the patient population. The corresponding median lung pneumonitis probability was 1.1% (range 0-14%). The median heart V(50) was 0.8% (range 0-19.1%) with a corresponding median cardiac mortality NTCP of 0.1% (range 0-5.7%). These results compare well with the predictions of our previous CT-studies. There is a significant reduction in dose to the left anterior descending coronary artery for the enhanced end-inspiration gating technique compared to the uncoached end-inspiration technique employed in the CT-studies.
CONCLUSIONS: In a routine clinical practice involving adjuvant breast radiotherapy gated in an enhanced end-inspiration phase, remarkably low doses to organs at risk are observed. The corresponding cardiac and pulmonary complication risks are of the order of 1% and smaller.

Entities:  

Mesh:

Year:  2006        PMID: 16905210     DOI: 10.1016/j.radonc.2006.07.020

Source DB:  PubMed          Journal:  Radiother Oncol        ISSN: 0167-8140            Impact factor:   6.280


  14 in total

1.  The dosimetric impact of inversely optimized arc radiotherapy plan modulation for real-time dynamic MLC tracking delivery.

Authors:  Marianne Falk; Tobias Larsson; Paul Keall; Byung Chul Cho; Marianne Aznar; Stine Korreman; Per Poulsen; Per Munck Af Rosenschold
Journal:  Med Phys       Date:  2012-03       Impact factor: 4.071

2.  Evaluation of dose to cardiac structures during breast irradiation.

Authors:  M C Aznar; S-S Korreman; A N Pedersen; G F Persson; M Josipovic; L Specht
Journal:  Br J Radiol       Date:  2010-12-15       Impact factor: 3.039

3.  Concomitant adjuvant chemo-radiation therapy with anthracycline-based regimens in breast cancer: a single centre experience.

Authors:  L Livi; I Meattini; V Scotti; C Saieva; G Simontacchi; L Marrazzo; C Franzese; S Cassani; F Paiar; V Di Cataldo; J Nori; L Jose Sanchez; S Bianchi; L Cataliotti; G Biti
Journal:  Radiol Med       Date:  2011-03-07       Impact factor: 3.469

Review 4.  Cardiac side effects of conventional and particle radiotherapy in cancer patients.

Authors:  A Wittig; R Engenhart-Cabillic
Journal:  Herz       Date:  2011-06       Impact factor: 1.443

5.  Target tracking using DMLC for volumetric modulated arc therapy: a simulation study.

Authors:  Baozhou Sun; Dharanipathy Rangaraj; Lech Papiez; Swetha Oddiraju; Deshan Yang; H Harold Li
Journal:  Med Phys       Date:  2010-12       Impact factor: 4.071

6.  Initial validation and clinical experience with 3D optical-surface-guided whole breast irradiation of breast cancer.

Authors:  S Li; T DeWeese; B Movsas; Dezhi Liu; Deborah Frassica; Jinkoo Kim; Qing Chen; Eleanor Walker
Journal:  Technol Cancer Res Treat       Date:  2012-02

7.  Real-time dynamic MLC tracking for inversely optimized arc radiotherapy.

Authors:  Marianne Falk; Per Munck af Rosenschöld; Paul Keall; Herbert Cattell; Byung Chul Cho; Per Poulsen; Sergey Povzner; Amit Sawant; Jens Zimmerman; Stine Korreman
Journal:  Radiother Oncol       Date:  2010-01-19       Impact factor: 6.280

8.  Motion management during IMAT treatment of mobile lung tumors--a comparison of MLC tracking and gated delivery.

Authors:  Marianne Falk; Tobias Pommer; Paul Keall; Stine Korreman; Gitte Persson; Per Poulsen; Per Munck af Rosenschöld
Journal:  Med Phys       Date:  2014-10       Impact factor: 4.071

9.  Comparison of doses and NTCP to risk organs with enhanced inspiration gating and free breathing for left-sided breast cancer radiotherapy using the AAA algorithm.

Authors:  Anneli Edvardsson; Martin P Nilsson; Sousana Amptoulach; Sofie Ceberg
Journal:  Radiat Oncol       Date:  2015-04-10       Impact factor: 3.481

Review 10.  Benefits, risks, and safety of external beam radiation therapy for breast cancer.

Authors:  Lindsay C Brown; Robert W Mutter; Michele Y Halyard
Journal:  Int J Womens Health       Date:  2015-04-24
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.